Wei, H., Zhou, C., Lin, D., Liu, B., Li, Y., Zhao, X., . . . Wang, J. (2020). Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia. Haematologica.
Citação norma ChicagoWei, Hui, et al. "Benefit of Intermediate-dose Cytarabine-containing Induction in Molecular Subgroups of Acute Myeloid Leukemia." Haematologica 2020.
MLA citiranjeWei, Hui, et al. "Benefit of Intermediate-dose Cytarabine-containing Induction in Molecular Subgroups of Acute Myeloid Leukemia." Haematologica 2020.
Opozorilo: Ti citati niso vedno 100% točni.